Skip to main content
Caplight Logo









Allarta Life Science

Allarta Life Science

Private
HamiltonHealthcare & Life Scienceshttps://allarta.com/

Last Round

Grant

Oct 2, 2023

Total Funding Raised

$2M

Company Overview

Allarta Life Science is a biotechnology company that develops proprietary biomaterial platforms for the immune-privileged delivery of cell and stem cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinecell encapsulationbiomaterialsallogeneic cell therapytype 1 diabetesimmune-privileged deliveryhydrogelstem cell therapybiotechdrug deliveryendocrine disorderscell transplantbiopharmapre-clinical researchcell therapy tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allarta Life Science Comparables

Compare Allarta Life Science with similar companies based on industry and business-model similarity.

Allarta Life Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Encellin
87%
ImmunoShield Therapeutics
86%
ALTuCELL
83%

Allarta Life Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 2, 2023
GrantAug 24, 2022

Key People

Founding team and executive leadership

Maria Antonakos

Founder and Chief Operating Officer

Founding Team

Harald Stover

Founder and Chief Executive Officer

Founding Team

Allarta Life Science Investors

Notable investors and investment history

Allarta Life Science investors
InvestorRounds
JDRFGrant
McMaster UniversityPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors grew 148% MoM, reaching 1.5K.

  • Oct 2, 2023

    $800K grant received from JDRF.

Allarta Life Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allarta Life Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allarta Life Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersHamilton
Employee Range34
Year Founded2019
Last FundingOct 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?